A novel small molecule inhibitor of the DNA repair protein Ku70/80.

[1]  Ji-Bin Liu,et al.  Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue. , 2015, International journal of pharmaceutics.

[2]  A. Tomkinson,et al.  Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. , 2014, Molecular cell.

[3]  K. O'Byrne,et al.  Chemotherapeutic Compounds Targeting the DNA Double-Strand Break Repair Pathways: The Good, the Bad, and the Promising , 2014, Front. Oncol..

[4]  A. Chinnaiyan,et al.  Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition. , 2013, Neoplasia.

[5]  David G. Kirsch,et al.  Strategies for optimizing the response of cancer and normal tissues to radiation , 2013, Nature Reviews Drug Discovery.

[6]  Nicola J. Curtin,et al.  DNA repair dysregulation from cancer driver to therapeutic target , 2012, Nature Reviews Cancer.

[7]  M. Laiho,et al.  Maintenance of genomic integrity after DNA double strand breaks in the human prostate and seminal vesicle epithelium: The best and the worst , 2012, Molecular oncology.

[8]  A. Kimmelman,et al.  Inhibition of Non-Homologous End Joining Repair Impairs Pancreatic Cancer Growth and Enhances Radiation Response , 2012, PloS one.

[9]  Ryan G. Coleman,et al.  ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..

[10]  Harry Jubb,et al.  Structural biology and drug discovery for protein-protein interactions. , 2012, Trends in pharmacological sciences.

[11]  Ralf Seip,et al.  Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Stéphanie Pérot,et al.  Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. , 2010, Drug discovery today.

[13]  J. Welsh,et al.  The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells , 2009, Radiation oncology.

[14]  C. Beskow,et al.  Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86 , 2009, British Journal of Cancer.

[15]  E. Hendrickson,et al.  Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells , 2008, Proceedings of the National Academy of Sciences.

[16]  E. Hendrickson,et al.  Mutations to Ku reveal differences in human somatic cell lines. , 2008, DNA repair.

[17]  N. Seki,et al.  Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo. , 2007, International journal of oncology.

[18]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[19]  T. Golub,et al.  Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells , 2004, Cancer Research.

[20]  J. Hoeijmakers,et al.  The role of DNA dependent protein kinase in synapsis of DNA ends , 2003, Nucleic acids research.

[21]  J. Walker,et al.  Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair , 2001, Nature.

[22]  G. Li,et al.  Ku autoantigen affects the susceptibility to anticancer drugs. , 1999, Cancer research.

[23]  S. Jackson,et al.  The DNA-dependent protein kinase , 1999 .

[24]  F. Alt,et al.  Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Hartmann-Petersen,et al.  The Ku70/80 ring in Non-Homologous End-Joining: easy to slip on, hard to remove. , 2016, Frontiers in bioscience.

[26]  David J. Chen,et al.  The endless tale of non-homologous end-joining , 2008, Cell Research.

[27]  R. Abagyan,et al.  Comprehensive identification of "druggable" protein ligand binding sites. , 2004, Genome informatics. International Conference on Genome Informatics.

[28]  N. Seki,et al.  Silencing Ku 80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo , 2022 .